Shmeylan Al Harbi
Overview
Explore the profile of Shmeylan Al Harbi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
652
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alrashed M, Alabdulkarim N, Alaskah J, Alsoket S, Almotairi R, Yami M, et al.
Clin Exp Emerg Med
. 2025 Jan;
PMID: 39807064
Objectives: The objective of this systematic review and meta-analysis is to evaluate the efficacy, safety, time to INR reversal, total volume of 4-factor prothrombin complex concentrate (PCC) administered of fixed-dose...
2.
Alrashed M, Alyousef A, Badreldin H, Bin Saleh K, Al Harbi S, Albekairy A, et al.
Diseases
. 2024 Dec;
12(12.
PMID: 39727662
Background: Acetaminophen is generally considered safe when used according to the recommended guidelines. Consumption in excessive doses can lead to severe liver damage and, in critical cases, may even result...
3.
Alshehri A, Alrashed M, Shawaqfeh M, Almutairi F, Alanazi A, Alfaifi M, et al.
J Clin Med
. 2024 Nov;
13(21).
PMID: 39518687
Hyperuricemia has been linked to various adverse clinical outcomes. Data on the clinical outcomes and the relationship between hyperuricemia and sepsis remain limited. The aim of this study was to...
4.
Aljuhani O, Korayem G, Altebainawi A, AlMohammady D, Alfahed A, Altebainawi E, et al.
BMC Infect Dis
. 2024 Feb;
24(1):189.
PMID: 38350878
Background: Dexamethasone usually recommended for patients with severe coronavirus disease 2019 (COVID-19) to reduce short-term mortality. However, it is uncertain if another corticosteroid, such as methylprednisolone, may be utilized to...
5.
Al Sulaiman K, Al-Ramahi G, Aljuhani O, Al-Joudi K, Alhujayri A, Al-Shomer F, et al.
Eur J Trauma Emerg Surg
. 2024 Jan;
50(2):567-579.
PMID: 38240791
Purpose: Venous thromboembolism (VTE) is a common complication in critically ill patients, including severe burn cases. Burn patients respond differently to medications due to pharmacokinetic changes. This study aims to...
6.
Alowais S, Alghamdi S, Alsuhebany N, Alqahtani T, Alshaya A, Almohareb S, et al.
BMC Med Educ
. 2023 Sep;
23(1):689.
PMID: 37740191
Introduction: Healthcare systems are complex and challenging for all stakeholders, but artificial intelligence (AI) has transformed various fields, including healthcare, with the potential to improve patient care and quality of...
7.
Aljuhani O, Korayem G, Altebainawi A, Alotaibi M, Alrakban N, Ghoneim R, et al.
Saudi Pharm J
. 2023 May;
31(7):1210-1218.
PMID: 37256102
Background: Oseltamivir has been used as adjunctive therapy in the management of patients with COVID-19. However, the evidence about using oseltamivir in critically ill patients with severe COVID-19 remains scarce....
8.
Alotaibi F, Alharbi N, Rosen L, Asiri A, Assiri A, Balkhy H, et al.
Influenza Other Respir Viruses
. 2023 Mar;
17(3):e13116.
PMID: 36960162
Background: Type I interferons (IFNs) are essential antiviral cytokines induced upon respiratory exposure to coronaviruses. Defects in type I IFN signaling can result in severe disease upon exposure to respiratory...
9.
Kensara R, Aljuhani O, Korayem G, Alkofide H, Almohareb S, Alosaimi Y, et al.
Clin Appl Thromb Hemost
. 2023 Feb;
29:10760296231156178.
PMID: 36789786
Atrial fibrillation (Afib) can contribute to a significant increase in mortality and morbidity in critically ill patients. Thus, our study aims to investigate the incidence and clinical outcomes associated with...
10.
Al Sulaiman K, Aljuhani O, Alhammad A, Al Aamer K, AlShehri S, Alhuwahmel A, et al.
Saudi Pharm J
. 2023 Jan;
30(12):1748-1754.
PMID: 36601502
Background: Colistin is considered a valuable and last-resort therapeutic option for MDR gram-negative bacteria. Nephrotoxicity is the most clinically pertinent adverse effect of colistin. Vivo studies suggest that administering oxidative...